Droperidol Articles
ProStrakan's 10-month sales jump 33%
24 November 2008
ProStrakan's early-2008 sales exceed projections
2 June 2008
ProStrakan's 2007 sales exceed expectations
21 January 2008
ProStrakan provides R&D update
8 October 2007
ProStrakan's 1st-half 2007 sales jump 15%
16 July 2007
J&J adds warning to Eprex labeling
6 December 2001
Cephalon to acquire Anesta in $444M deal
18 July 2000
Russian Move To Generics Sector Is Forecast
9 September 1997
ZOFRAN APPROVED IN UK FOR PONV
11 May 1992
Showing 1-9 of 9 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
